Verition Fund Management
AVNS

Verition Fund Management’s Avanos Medical AVNS Stock Holding History

Verition Fund Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.97M Buy
+320,442
New +$7.5M 0.04% 449
2026
Q1 		– Sell
-17,600
Closed -$198K – 2328
2025
Q4 		$198K Sell
17,600
-40,134
-70% -$459K ﹤0.01% 3181
2025
Q3 		$667K Sell
57,734
-45,254
-44% -$530K ﹤0.01% 2846
2025
Q2 		$1.26M Sell
102,988
-30,928
-23% -$389K 0.01% 2296
2025
Q1 		$1.92M Buy
133,916
+119,416
+824% +$1.86M 0.01% 1607
2024
Q4 		$231K Buy
+14,500
New +$287K ﹤0.01% 2916
2024
Q2 		– Sell
-16,047
Closed -$319K – 2982
2024
Q1 		$319K Buy
+16,047
New +$310K ﹤0.01% 2264
2021
Q3 		– Sell
-8,296
Closed -$302K – 1893
2021
Q2 		$302K Buy
8,296
+3,213
+63% +$133K ﹤0.01% 1338
2021
Q1 		$222K Buy
+5,083
New +$239K ﹤0.01% 1276
2018
Q4 		– Sell
-5,768
Closed -$395K – 827
2018
Q3 		$395K Buy
+5,768
New +$371K 0.01% 927
2017
Q2 		– Sell
-12,453
Closed -$474K – 924
2017
Q1 		$474K Buy
12,453
+4,571
+58% +$178K 0.04% 588
2016
Q4 		$291K Buy
+7,882
New +$282K 0.03% 844
2015
Q1 		– Sell
-7,165
Closed -$326K – 390
2014
Q4 		$326K Buy
+7,165
New +$281K 0.07% 129

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Verition Fund Management's AVNS Position: Q2 2026 in Review

Verition Fund Management opened a new position in Avanos Medical (AVNS) in Q2 2026: 320,442 shares worth $7.97M. The stake represents 0.04% of the portfolio and ranks #449 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in AVNS as recently as Q4 2025.

Verition Fund Management first reported a position in AVNS in Q4 2014 and has held it in 13 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Verition Fund Management held 320,442 shares of Avanos Medical worth $7.97M as of Q2 2026.
  • Avanos Medical was a new Verition Fund Management position in Q2 2026.
  • Avanos Medical made up 0.04% of Verition Fund Management's portfolio in Q2 2026, its #449 holding.
  • Verition Fund Management first reported a position in Avanos Medical in Q4 2014 and has held it in 13 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.